Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

ProQR concludes QR-010 dosing in Phase Ib trial to treat cystic fibrosis

Go Top